XOLAIR
Dead / Cancelled — Cancelled — Section 8 (as of 27 Oct 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78109911
- Registration number
- 2707154
- Mark type
- Word mark
- Filed
- 20 Feb 2002
- Published for opposition
- 21 Jan 2003
- Registered
- 15 Apr 2003
- Next maintenance due
- 15 Apr 2013
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of rhinitis
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 27 Oct 2023 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 15 Apr 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Mar 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Mar 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 Mar 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Mar 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Feb 2013 — TEAS SECTION 8 & 9 RECEIVED
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Apr 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Jan 2009 — ASSIGNED TO PARALEGAL
- 06 Jan 2009 — TEAS SECTION 8 & 15 RECEIVED
- 20 Mar 2008 — CASE FILE IN TICRS
- 04 Dec 2004 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Nov 2004 — PAPER RECEIVED